🇺🇸 Vibramycin in United States
758 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 758
Most-reported reactions
- Drug Hypersensitivity — 136 reports (17.94%)
- Diarrhoea — 90 reports (11.87%)
- Dyspnoea — 83 reports (10.95%)
- Fatigue — 76 reports (10.03%)
- Nausea — 75 reports (9.89%)
- Pain — 66 reports (8.71%)
- Pyrexia — 66 reports (8.71%)
- Rash — 66 reports (8.71%)
- Acute Kidney Injury — 50 reports (6.6%)
- Vomiting — 50 reports (6.6%)
Other Other approved in United States
Frequently asked questions
Is Vibramycin approved in United States?
Vibramycin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Vibramycin in United States?
Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.